These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36650958)

  • 41. Different trajectories in upper limb and gross motor function in spinal muscular atrophy.
    Coratti G; Pera MC; Montes J; Pasternak A; Scoto M; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; De Sanctis R; Mazzone ES; Milev E; Rohwer A; Civitello M; Pane M; Antonaci L; Frongia AL; Sframeli M; Vita GL; DʼAmico A; Mizzoni I; Albamonte E; Darras BT; Bertini E; Sansone VA; Bovis F; Day J; Bruno C; Muntoni F; De Vivo DC; Finkel R; Mercuri E
    Muscle Nerve; 2021 Nov; 64(5):552-559. PubMed ID: 34327716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A qualitative study of perceptions of meaningful change in spinal muscular atrophy.
    McGraw S; Qian Y; Henne J; Jarecki J; Hobby K; Yeh WS
    BMC Neurol; 2017 Apr; 17(1):68. PubMed ID: 28376816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability and validity of the Turkish version of the Upper Limb Short Questionnaire in Duchenne muscular dystrophy.
    Savaş D; Tarsuslu T
    Somatosens Mot Res; 2023 Jun; 40(2):56-61. PubMed ID: 36538388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanding traditional tendon-based techniques with nerve transfers for the restoration of upper limb function in tetraplegia: a prospective case series.
    van Zyl N; Hill B; Cooper C; Hahn J; Galea MP
    Lancet; 2019 Aug; 394(10198):565-575. PubMed ID: 31280969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanding the phenotype of DYNC1H1-associated diseases with a rare variant resulting in spinal muscular atrophy with lower extremity predominance (SMA-LED) and upper motor neuron signs.
    Lee J; Millington P; Dayasiri K; Ramdas S; Jayawant S; Anand G
    Turk J Pediatr; 2023; 65(3):531-535. PubMed ID: 37395972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and validation of a motor function classification in patients with neuromuscular disease: the NM-score.
    Vuillerot C; Rippert P; Roche S; Bérard C; Margirier F; de Lattre C; Poirot I; Berruyer A; Tiffreau V; Fournier-Mehouas M; Bouhour F; Urtizberea JA; Renders A; Ecochard R;
    Ann Phys Rehabil Med; 2013 Dec; 56(9-10):673-86. PubMed ID: 24231198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study.
    Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA
    Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes.
    Coratti G; Carmela Pera M; Montes J; Scoto M; Pasternak A; Bovis F; Sframeli M; D'Amico A; Pane M; Albamonte E; Antonaci L; Lia Frongia A; Mizzoni I; Sansone VA; Russo M; Bruno C; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; de Sanctis R; Stacy Mazzone E; Milev E; Rohwer A; Civitello M; Darras BT; Bertini E; Day J; Muntoni F; De Vivo DC; Finkel RS; Mercuri E
    Neuromuscul Disord; 2022 Jan; 32(1):36-42. PubMed ID: 34980538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of bone mineral density, bone metabolism and fragility fractures in Spinal Muscular Atrophy (SMA) types 2 and 3.
    Baranello G; Vai S; Broggi F; Masson R; Arnoldi MT; Zanin R; Mastella C; Bianchi ML
    Neuromuscul Disord; 2019 Jul; 29(7):525-532. PubMed ID: 31266719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies.
    Darras BT; Chiriboga CA; Iannaccone ST; Swoboda KJ; Montes J; Mignon L; Xia S; Bennett CF; Bishop KM; Shefner JM; Green AM; Sun P; Bhan I; Gheuens S; Schneider E; Farwell W; De Vivo DC;
    Neurology; 2019 May; 92(21):e2492-e2506. PubMed ID: 31019106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.
    Chabanon A; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Cuisset JM; Laugel V; Schara U; Gidaro T; Gilabert S; Hogrel JY; Baudin PY; Carlier P; Fournier E; Lowes LP; Hellbach N; Seabrook T; Toledano E; Annoussamy M; Servais L;
    PLoS One; 2018; 13(7):e0201004. PubMed ID: 30048507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients.
    Mazzone E; De Sanctis R; Fanelli L; Bianco F; Main M; van den Hauwe M; Ash M; de Vries R; Fagoaga Mata J; Schaefer K; D'Amico A; Colia G; Palermo C; Scoto M; Mayhew A; Eagle M; Servais L; Vigo M; Febrer A; Korinthenberg R; Jeukens M; de Viesser M; Totoescu A; Voit T; Bushby K; Muntoni F; Goemans N; Bertini E; Pane M; Mercuri E
    Neuromuscul Disord; 2014 Apr; 24(4):347-52. PubMed ID: 24491485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reliability and validity of upper limb short questionnaire for Duchenne muscular dystrophy.
    Choi YA; Shin HI
    Disabil Rehabil; 2022 Jun; 44(11):2448-2455. PubMed ID: 33027595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing upper limb function in nonambulant SMA patients: development of a new module.
    Mazzone E; Bianco F; Martinelli D; Glanzman AM; Messina S; De Sanctis R; Main M; Eagle M; Florence J; Krosschell K; Vasco G; Pelliccioni M; Lombardo M; Pane M; Finkel R; Muntoni F; Bertini E; Mercuri E
    Neuromuscul Disord; 2011 Jun; 21(6):406-12. PubMed ID: 21421316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
    Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
    Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.
    Bendixen RM; Butrum J; Jain MS; Parks R; Hodsdon B; Nichols C; Hsia M; Nelson L; Keller KC; McGuire M; Elliott JS; Linton MM; Arveson IC; Tounkara F; Vasavada R; Harnett E; Punjabi M; Donkervoort S; Dastgir J; Leach ME; Rutkowski A; Waite M; Collins J; Bönnemann CG; Meilleur KG
    Neuromuscul Disord; 2017 Mar; 27(3):278-285. PubMed ID: 28087121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta-analysis.
    Pascual-Morena C; Martínez-Vizcaíno V; Cavero-Redondo I; Martínez-García I; Moreno-Herráiz N; Álvarez-Bueno C; Saz-Lara A
    Pharmacotherapy; 2024 Jan; 44(1):97-105. PubMed ID: 37574770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliability of home-based, motor function measure in hereditary neuromuscular diseases.
    Ruiz-Cortes X; Ortiz-Corredor F; Mendoza-Pulido C
    J Int Med Res; 2017 Feb; 45(1):261-271. PubMed ID: 28222643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlates of Fatigability in Patients With Spinal Muscular Atrophy.
    Bartels B; de Groot JF; Habets LE; Wadman RI; Asselman FL; Nieuwenhuis EES; van Eijk RPA; Goedee HS; van der Pol WL
    Neurology; 2021 Feb; 96(6):e845-e852. PubMed ID: 33219141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.